COVID-19 Organ Injury Pathology and D-Dimer Expression Patterns: A Retrospective Analysis

Raluca Dumache1,2, Camelia Oana Muresan1,2, Sorina Maria Denisa Laitin3

  • 1Department of Forensic Medicine, Bioethics, Medical Ethics and Medical Law, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

PubMed

Insights

Elevated D-dimer levels in COVID-19 patients correlate with increased multi-organ damage, particularly in the lungs and heart. This highlights hypercoagulability

Area of Science:

  • Pathology
  • Hematology
  • Infectious Diseases

Background:

  • Coronavirus Disease 2019 (COVID-19) can lead to widespread organ damage.
  • Hypercoagulability, indicated by elevated D-dimer, is a known COVID-19 complication.
  • The relationship between D-dimer levels and specific organ pathology in COVID-19 requires further elucidation.

Purpose of the Study:

  • To evaluate pathological changes in COVID-19 patients.
  • To analyze organ-specific lesions in relation to D-dimer levels.
  • To investigate the prognostic significance of D-dimer in COVID-19 outcomes.

Main Methods:

  • Retrospective review of 69 COVID-19 autopsied or deceased patients.
  • Cataloging of pathological findings: pulmonary microthrombi, bronchopneumonia, myocardial fibrosis, hepatic steatosis, renal tubular necrosis.
  • Subgroup analysis based on D-dimer categories (<500, 500-2000, ≥2000 ng/mL) and correlation with clinical/laboratory data.

Main Results:

  • Marked organ pathology was significantly more frequent in the highest D-dimer group (≥2000 ng/mL).
  • Pulmonary, myocardial, and renal lesions showed increased prevalence with higher D-dimer levels.
  • Severe lung and heart pathologies correlated with high inflammatory markers and increased risk of ICU admission and mortality.

Conclusions:

  • COVID-19-related organ damage is amplified in patients with significantly elevated D-dimer.
  • Hypercoagulability and systemic inflammation play a crucial role in multi-organ complications.
  • D-dimer stratification can guide tailored management for high-risk COVID-19 patients.